• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Substernal gastric bypass of the excluded esophagus--results of an ill-advised operation.

作者信息

Orringer M B

出版信息

Surgery. 1984 Sep;96(3):467-70.

PMID:6206582
Abstract

Substernal gastric bypass of the excluded thoracic esophagus for palliation of esophageal carcinoma was proposed as a method of providing maximum patient comfort with minimum morbidity. Our results with this operation in 37 patients are reviewed and indicate that the procedure carries unacceptable complication and mortality rates. Among our patients, there have been nine (24%) hospital deaths, seven (19%) anastomotic leaks, and six (17%) disruptions of the divided distal thoracic esophagus. Major postoperative complications have occurred in 59% of these patients. Only 15 (54%) of the 28 survivors were discharged swallowing within 3 weeks of operation, and 10 (36%) required hospitalization for 1 month or longer after operation. The average survival time in those leaving the hospital alive has been only 5.9 months. Only seven patients (25% of the survivors) have achieved good palliation with the bypass procedure. It is concluded that substernal gastric bypass of the excluded thoracic esophagus is too much of an operation for patients with unresectable tumors who have a life expectancy of only several months.

摘要

相似文献

1
Substernal gastric bypass of the excluded esophagus--results of an ill-advised operation.
Surgery. 1984 Sep;96(3):467-70.
2
Substernal gastric bypass of the excluded thoracic esophagus for palliation of esophageal carcinoma.
J Thorac Cardiovasc Surg. 1975 Nov;70(5):836-51.
3
[Retrosternal gastric bypass in the palliative treatment of advanced carcinoma of the thoracic esophagus].
Chir Ital. 1984 Oct;36(5):760-72.
4
Gastro-esophageal isoperistaltic bypass in the palliation of irresectable thoracic esophageal cancer.
Int Surg. 1997 Jul-Sep;82(3):249-53.
5
Retrosternal bypass operation for unresectable squamous cell cancer of the esophagus.不可切除的食管鳞状细胞癌的胸骨后旁路手术
Ann Thorac Surg. 1996 Aug;62(2):373-7.
6
The effectiveness of palliative resection for advanced esophageal carcinoma: analysis of 24 consecutive cases.晚期食管癌姑息性切除术的疗效:24例连续病例分析
Surg Today. 2002;32(9):784-8. doi: 10.1007/s005950200150.
7
[Results of the treatment of carcinoma of the thoracic esophagus with one-stage resection and esophagogastrostomy].[胸段食管癌一期切除及食管胃吻合术的治疗结果]
Chir Ital. 1984 Aug;36(4):589-602.
8
[The nonexcisional palliative surgical treatment of carcinoma of the thoracic esophagus and cardia].[胸段食管癌与贲门癌的非切除性姑息性外科治疗]
Rev Esp Enferm Dig. 1994 Jun;85(6):419-22.
9
Intrathoracic gastric and jejunal bypass for palliation of nonresectable esophageal carcinoma.
Int Surg. 1982 Apr-Jun;67(2):147-51.
10
Esophageal exclusion and gastric bypass for unresectable carcinoma of the thoracic esophagus.食管旷置术及胃旁路术治疗不可切除的胸段食管癌。
Indian J Gastroenterol. 1989 Apr;8(2):77-9.

引用本文的文献

1
Robotic substernal esophageal bypass and reconstruction with gastric conduit-frequently overlooked minimally invasive option.机器人辅助胸骨后食管旁路术及胃管道重建术——常被忽视的微创选择
J Vis Surg. 2019 May;5. doi: 10.21037/jovs.2019.04.02. Epub 2019 May 7.
2
Comparative study of self-expanding metal stent and intraluminal radioactive stent for inoperable esophageal squamous cell carcinoma.自膨式金属支架与腔内放射性支架治疗不可切除食管鳞状细胞癌的对比研究
World J Surg Oncol. 2016 Jan 22;14(1):18. doi: 10.1186/s12957-016-0768-x.
3
Complications after ultrasonic lung parenchyma biopsy: a strong note for caution.
Surg Endosc. 2008 Mar;22(3):679-82. doi: 10.1007/s00464-007-9460-0.
4
Comparison of different treatments for unresectable esophageal cancer.不可切除食管癌不同治疗方法的比较。
World J Surg. 1995 Nov-Dec;19(6):828-35. doi: 10.1007/BF00299779.
5
Surgical management of carcinoma of the esophagus.食管癌的外科治疗
Bull N Y Acad Med. 1993 Jan-Feb;69(1):33-8.
6
Anastomotic leakage after resection and bypass for esophageal cancer: lessons learned from the past.食管癌切除及旁路术后吻合口漏:从过去吸取的教训
World J Surg. 1989 Jul-Aug;13(4):472-7. doi: 10.1007/BF01660760.
7
Motor function in the excluded esophagus and its implications in the management of patients with unresectable carcinoma of the esophagus.被排除食管段的运动功能及其在不可切除食管癌患者管理中的意义。
Ann Surg. 1987 Dec;206(6):787-90. doi: 10.1097/00000658-198712000-00017.
8
Light at the end of the tunnel? Palliation for oesophageal carcinoma.曙光在前?食管癌的姑息治疗。
Gut. 1987 Jul;28(7):781-5. doi: 10.1136/gut.28.7.781.
9
Endoscopic Nd-YAG laser therapy as palliative treatment for esophageal and cardial cancer. Parameters affecting long-term outcome.内镜下钕钇铝石榴石激光治疗作为食管癌和贲门癌的姑息治疗。影响长期疗效的参数。
Dig Dis Sci. 1990 Mar;35(3):294-301. doi: 10.1007/BF01537405.